A

  • Analysis Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]

B

  • Brain Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]

C

  • Cisplatin Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]

  • Creatinine Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]

D

  • Demographic Investigation of Health Status with Psychological Aspects [Volume 1, Issue 1, 2019, Page 29-34]

  • Diagnosis Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]

E

  • Expression Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]

G

  • General Health Investigation of Health Status with Psychological Aspects [Volume 1, Issue 1, 2019, Page 29-34]

  • Glioma Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]

I

  • Imaging Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]

  • Injury Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]

K

  • Kidney Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]

M

  • Magnetic resonance imaging Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]

  • Marker Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]

  • Medical Staff Investigation of Health Status with Psychological Aspects [Volume 1, Issue 1, 2019, Page 29-34]

  • Mental Disorders Investigation of Health Status with Psychological Aspects [Volume 1, Issue 1, 2019, Page 29-34]

  • Multiple sclerosis Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]

N

  • Neuropathology Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]

P

  • PCR Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]

S

  • Serum Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]

  • Spinal Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]

U

  • Urinary Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]